Genetic Testing May Alter Care for Almost Half with Neurodevelopmental Disorders

A study looking at medical records for 316 children treated at a multidisciplinary clinic at the University of California, Los Angeles, 42% who did genetic testing learned that they had or likely had a rare genetic condition. The diagnoses led some children to change medications or be referred to a clinical trial.

“This study shows that taking a genetics-informed approach to neuropsychiatric care can make a meaningful difference for patients with neurodevelopmental disorders,” said Dr. Aaron Besterman of Rady Children’s Institute for Genomic Medicine in San Diego, a senior author of the study.

Many Adverse Drug Reactions (ADRs) can be mitigated by finding the best medication based on a patient's genetics - saving months and even years of complication.

For enquiries on Genomind, feel free to reach out to our SciencewerkeDX sales representative br> [email protected] or call +65 98254866.